Refine Search
(179)
(196)
(753)
(1689)

sfRowasa (Ulcerative Colitis) - Forecast and Market Analysis to 2022

  • $3,495
  • January 2008
Add to Basket Quick View Add to Saved List

During the forecast period from 2012–2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients bei...

EpiCast Report: Diabetic Foot Ulcers - Epidemiology Forecast to 2022

  • $3,995
  • October 2008
Add to Basket Quick View Add to Saved List

Diabetic foot ulcers (DFUs) are a major complication of diabetes and the most common foot injury in diabetics. DFUs occur as a result of trauma to or extreme pressure on any part of the foot in diabetics. The lifetime risk of an individual with...

Pituitary Tumors Global Clinical Trials Review, Q4, 2010

  • $1,000
  • December 2010
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Pituitary Tumors Global Clinical Trials Review, Q4, 2010" provides data on the Pituitary Tumors clinical trial scenario. This report provides in-depth information and data relating to the clinical...

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – January 2011

  • $1,000
  • January 2011
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals January 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and fi...

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2010

  • $1,500
  • January 2011
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2010” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and finan...

Insulin Resistance Global Clinical Trials Review, Q1, 2011

  • $1,000
  • February 2011
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Insulin Resistance Global Clinical Trials Review, H1, 2012" provides data on the Insulin Resistance clinical trial scenario. This report provides elemental information and data relating to the clini...

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - February 2011

  • $1,000
  • February 2011
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals February 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and f...

Pharmaceutical & Healthcare Annual Deals Analysis 2011

  • $3,500
  • February 2011
Add to Basket Quick View Add to Saved List

GlobalData's “Pharmaceutical & Healthcare Annual Deals Analysis 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and health...

BioDelivery Sciences International Prices Private Placement of $15m

  • $1,000
  • March 2011
Add to Basket Quick View Add to Saved List

GlobalData’s report, “BioDelivery Sciences International Prices Private Placement of $15m” provides key information on future plans of BioDelivery Sciences International. This report wil provide a background of the products being developed by t...

BioDelivery Sciences International Prices Private Placement of $15m

  • $1,000
  • March 2011
Add to Basket Quick View Add to Saved List

GlobalData’s report, “BioDelivery Sciences International Prices Private Placement of $15m” provides key information on future plans of BioDelivery Sciences International. This report wil provide a background of the products being developed by t...

International Stroke Conference 2011: Review and Analysis

  • $1,000
  • March 2011
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its new conference alerts, “International Stroke Conference 2011: Review and Analysis”. The conference alert is an essential source of information and analysis on the emerging therapies...

2nd World Congress on Controversies in Ophthalmology 2011: Post-Conference Review and Analysis

  • $1,000
  • March 2011
Add to Basket Quick View Add to Saved List

GlobalData’s report, “2nd World Congress on Controversies in Ophthalmology 2011: Post-Conference Review and Analysis” provides key information fact discussed in the conference

The 10th International Conference on Alzheimer’s and Parkinson’s Diseases: Post-Conference Review and Analysis

  • $1,000
  • March 2011
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its new conference alert, “The 10th International Conference on Alzheimer’s and Parkinson’s Diseases”. The conference alert is an essential source of information and analysis on the eme...

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – March 2011

  • $1,000
  • March 2011
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals March 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and fina...

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - April 2011

  • $1,000
  • March 2011
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals April 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and fina...

Join our mailing list
Find out first about the latest reports and offers.
Report Catalogue

Strategic Insight Reports

Market Analysis Reports

Databooks